Kramer Kelly A. 4
4 · GILEAD SCIENCES, INC. · Filed May 8, 2025
Insider Transaction Report
Form 4
Kramer Kelly A.
Director
Transactions
- Award
Restricted Stock Unit
2025-05-07+1,516→ 19,110 total→ Common Stock (1,516 underlying) - Award
Non-qualified Stock Option (Right to Buy)
2025-05-07+6,809→ 6,809 totalExercise: $98.90Exp: 2035-05-07→ Common Stock (6,809 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]100% of the restricted stock units vested immediately upon the grant date of May 7, 2025.
- [F3]100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025.